While NLRC4-dependent sensing of intracellular Gram-negative pathogens such as Salmonella enterica serovar typhimurium is a beneficial host response, NLRC4-dependent sensing of the Pseudomonas aeruginosa type 3 secretion system (T3SS) has been shown to be involved in pathogenicity. In mice, different pathogen-associated microbial patterns are sensed by the combination of the NLRC4-inflammasome with different neuronal apoptosis inhibitory proteins (NAIPs). NAIP2 is involved in sensing PscI, an inner-rod protein of the P. aeruginosa T3SS. Surprisingly, only a single human NAIP (hNAIP) has been found. Moreover, there is no description of hNAIP-NLRC4 inflammasome recognition of T3SS inner-rod proteins in humans. Here, we show that the P. aeruginosa T3SS inner-rod protein PscI and needle protein PscF are both sensed by the hNAIP-NLRC4 inflammasome in human macrophages and PBMCs from healthy donors, allowing caspase-1 and IL-1β maturation and resulting in a robust inflammatory response. TLR4 and TLR2 are involved in redundantly sensing these two T3SS components.
Introduction
Pseudomonas aeruginosa is an opportunistic Gram-negative pathogen responsible for pneumonia, bloodstream and urinary tract infections, mainly in healthcare settings. Of note, P. aeruginosa was the only opportunistic bacteria to be independently associated with increased mortality in intensive care unit patients (1) . An important determinant of P. aeruginosa virulence is the capacity to harbor a specific virulence factor, the type 3 secretion system (T3SS). The T3SS is a multiprotein complex, composed of > 20 proteins that allow P. aeruginosa to inject four exotoxins (ExoS, ExoT, ExoY and ExoU) into host cells through a needle-like appendage and a translocation pore inserted into the cytoplasmic membrane of the host cell. Aside from various cytotoxic effects, these exotoxins are also known to interfere with several host factors involved in cellular defense (2) . Interestingly, we previously demonstrated that the T3SS itself, independently from the four exotoxins, could exploit a host innate immune sensor, the NLRC4-inflammasome to the detriment of the host (3) .
The NLRC4-inflammasome belongs to the large family of Nod-like receptors (NLRs) that allow host cells to sense pathogen-associated microbial patterns (PAMPs) (4) . Upon recognition of PAMPs, NLRs activate a protein complex (inflammasome) leading to caspase-1-dependent maturation of IL-1β, a major host-response cytokine. Among Gramnegative PAMPs, NLRC4 has been shown to sense proteins from the flagella, the T3SS needle and the inner rod of the T3SS that connects the needle to the base of the T3SS. In mice, it has been shown that these different microbial patterns are recognized by the combination of NLRC4 with different members of another family of NLRs, neuronal apoptosis inhibitory proteins (NAIPs): NAIP1, NAIP2, NAIP5 and NAIP6. Thus, NAIP2 senses rod proteins such as PrgJ from Salmonella or PscI from Pseudomonas, whereas NAIP5 and NAIP6 sense flagellins, and NAIP1 remains an orphan receptor (5) (6) (7) . Surprisingly, only a single human NAIP (hNAIP) has been found in humans (8) . Although hNAIP is homologous to murine NAIP5, hNAIP senses the T3SS needle protein PrgI rather than the flagellin in Salmonella infection (8) . Therefore, there is no description of hNAIP-NLRC4 inflammasome recognition of P. aeruginosa T3SS inner-rod proteins in humans.
We recently described for the first time the structural role of the P. aeruginosa T3SS inner-rod protein PscI within the apparatus (9) . Interestingly, we found that the secondary structure of PscI folding shares singularities compared to inner-rod proteins of other Gram-negative pathogens such as PrgJ from Salmonella sp. Furthermore, in a cellular model of Salmonella enterica serovar typhimurium, it was demonstrated that PrgJ is not sensed in human cell lines (8) .
Because of the structural differences between the T3SS inner-rod proteins of Salmonella and Pseudomonas, PscI and PrgJ, we hypothesize that PscI may yet be sensed by the human hNAIP-NLRC4-inflammasome.
Methods

THP-1 cell culture
THP-1 cells (ATCC TIB-202) were grown in ATCC-formulated RPMI-1640 supplemented with 10% heat-inactivated fetal bovine serum (Gibco® Life Sciences, Thermo Fisher Scientific Inc., Waltham, MA, USA), 1% Penicillin-Streptomycin and 0.05 mM 2-mercaptoethanol. Cells were maintained in a humidified atmosphere with 5% CO 2 at 37°C. THP-1 cells were seeded in culture plates (Greiner Bio-One, Frickenhausen, Germany) before induction of differentiation by contact with 100 nM of PMA for 48 h. The day before the challenge, cells were washed once with sterile PBS followed by fresh medium without antibiotic, for 24 h.
PBMC isolation
Peripheral venous blood was sampled following informed consent from volunteers. PBMCs were separated from blood collected into Vacutainer® tubes containing lithium/heparin by Ficoll (GE Healthcare Bio-Sciences AB, Uppsala, Sweden) gradient (density 1.077 g ml -1 ). PBMCs were isolated and washed twice before being seeded in culture plates.
Protein, TLR inhibitor and antibodies
To compare the activity of PscI, we also used two other T3SS components: PopB, a part of the pore-forming translocon localized at the tip of the T3SS, and PscF, a structural protein that forms the T3SS needle. As a positive control, we used the Salmonella needle protein PrgI homolog of PscF which was purchased from MyBioSource (San Diego, CA, USA). All T3SS proteins, PscI, PscF and PopB, were purified as previously described (9, 10) . LPS Ultrapure (used as a non-T3SS comparator), heat-killed Listeria monocytogenes (HKLM), Monosodium Urate (MSU) Crystals, polyclonal antibody (PAb) and human TLR2 polyclonal antibody [(hTLR2)PAb], TLR4 inhibitor CLI-095 and the NLRP3 inhibitor Bay11-7082 were purchased from Invivogen (San Diego, CA, USA). Inhibitors were used following the manufacturer's instructions.
siRNA transfection
For siRNAs knockdown, THP-1 cells were differentiated in 24-well plates (10 6 cells per well). siRNAs specific for NLRC4 and NAIP1 were transfected into macrophages using a siRNA Reagent System (sc-45064, Santa Cruz Biotechnology, Santa Cruz, CA, USA) according to the manufacturer's instructions. siRNAs were purchased from Santa Cruz Biotechnology.
Gene expression analysis
For gene expression analysis, cells were harvested immediately after challenge and total RNA was extracted using RNeasy Plus Mini Kit (Qiagen, Valencia, CA, USA) according to the manufacturer's instructions. Isolated RNA was reverse-transcribed with the High-Capacity cDNA Reverse Transcription kit (Applied Biosystems, Foster city, CA, USA). The resulting cDNA was amplified using the KAPA SYBR® FAST qPCR Kit and detected on a Prism 7900HT system (Applied Biosystems) with the following cycling parameters: initial denaturation at 95°C for 4 min followed by 40 cycles of 95°C for 5 s and 60°C for 30 s. On completion of the PCR amplification, a DNA melting curve analysis was carried out to confirm the presence of a single amplicon. GAPDH was used as an internal reference gene to normalize the transcript levels. Relative mRNA levels (2-ΔΔC t ) were determined by comparing (i) the PCR cycle thresholds (C t ) for the gene of interest and GAPDH (ΔC t ) and (ii) ΔC t values for the treated and control groups (ΔΔC t ).
Western blot analysis of caspase-1 activation and IL-1β maturation assays
Cells were seeded in six-well plates (4 × 10 6 cells per well) and stimulated over 6 h with PscI, PscF, PopB or LPS at 2 µg per well. The supernatants of stimulated macrophage cells were subjected to methanol/chloroform protein precipitation. The precipitates were re-suspended in Laemmli sample buffer and analyzed by western blot for caspase-1 or IL-1β using the corresponding antibodies. Cell lysates were blotted to assay pro-caspase-1 or pro-IL-1β and actin to control equal loading.
Lactate dehydrogenase release and cytokines analysis
Cell death was measured by the lactate dehydrogenase (LDH) assay using Cytotoxicity Detection kit (Roche, Mannheim, Germany) following the manufacturer's instructions. Human cytokines, IL-6, IL-1β and TNF-α were measured in culture supernatants using ELISA kits from Peprotech (Neuilly Sur Seine, France). Assays were performed in sextuplicate for each independent experiment.
Statistical analysis
Statistical analysis was carried out using Prism v5 software (Graph-Pad Software, San Diego, CA, USA). Values are expressed as mean ± SEM. Comparison groups were analyzed with the non-parametric Mann-Whitney test (*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001). A, B) was differentiated into macrophages with PMA and PBMCs (C) were isolated from peripheral venous blood. Cells were seeded in 96-well culture plates and treated with fresh medium or 500 ng per well of PscI, PscF, PopB or LPS. Twenty-four hours post-contact, cytotoxicity, IL-1β, IL-6 and TNF-α secretion (A, C) was determined by LDH release and ELISA. Relative gene expression (B) was determined, 2 h post-contact, by quantitative RT-PCR for IL-1β, IL-6, TNF-α, IL-8 and IL23p19. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001 compared to control.
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Results and discussion
The inner-rod protein PscI, the needle protein PscF, the poreforming toxin PopB, LPS and PrgI were all cytotoxic, leading to increased LDH release by human macrophages (Fig. 1A) .
Likewise, all induced a concurrent pro-inflammatory response (mainly IL-1β, IL-6 and TNF; Fig. 1B) . Consistently, we observed the same cytokine profile with PBMCs (Fig. 1C) . These profiles are in line with known inflammatory cytotoxic pathways such as IL-6, TNF-α and pro-IL-1β known to be usually regulated by TLR signaling and the mature IL-1β known to be regulated by NLRs.
Blocking TLR4 signaling through CLI-095 inhibited induction of IL-1β, IL-6 and TNF by PscI and PscF ( Fig. 2A) in human macrophages compared to the known TLR4 ligand, LPS. Since ELISA cannot differentiate the mature form of IL-1β from the immature pro-IL-1β, this decrease in IL-1β through blocking TLR4 is probably due to a decrease in pro-IL-1β. Likewise, blocking TLR2 with antibodies attenuates induction of IL-1β, IL-6 and TNF by both PscI and PscF compared to the TLR2 ligand, HKLM (Fig. 2B) .
It has been previously shown that other T3SS needle proteins, YscF from Yersinia and PrgI from Salmonella, elicit both TLR2 and TLR4 signaling (Fig. 2) (11) . Given the magnitude of response inhibition using either TLR4 or TLR2 blockers, we show that PscI and PscF are mainly sensed by TLR4 and to a lesser extent by TLR2. Our data are the first that describe TLR-dependent signaling of the inner-rod protein PscI of P. aeruginosa. Finally, the similar TLR-dependent recognition of both PscI and PscF suggests a redundancy in the sensing of the opportunistic P. aeruginosa T3SS.
However, blocking either TLR4 or TLR2 does not modify the induction of IL-1β, IL-6 and TNF by PopB compared to the TLR4 or TLR2 ligand controls, LPS and HKLM. Therefore, PopB does not seem to trigger either TLR2 nor TLR4 signaling in infected human macrophages, as is the case for other pore-forming toxins (12) .
To further characterize the increase in IL-1β secretion after challenge with P. aeruginosa T3SS proteins, we also assessed whether this increase was associated with IL-1β maturation: maturation of pro-caspase-1 into caspase-1 which cleaves pro-IL-1β into IL-1β. Western blotting revealed the presence of mature caspase-1 (Fig. 3A) and IL-1β (Fig. 3B) in the supernatants of human macrophages incubated with PscI, PscF and PopB, but not LPS. The P. aeruginosa needle protein PscF was previously described to induce caspase-1 maturation. Our data confirm this and additionally show that the P. aeruginosa innerrod protein PscI induces the same caspase-1 maturation as well as a same cytokine profile as observed with PscF (13) .
Given that PscI and PscF induce IL-1β and caspase-1 maturation (Fig. 3) , we suspected the implication of NLR signaling. In mice, T3SS inner-rod proteins are sensed by the NLRC4-inflammasome, and pore-forming toxins are sensed by the NLRP3-inflammasome (12, 14, 15) . We therefore checked whether NLRC4 (hNAIP-NLRC4 in humans) could be responsible for LDH release and IL-1β maturation, and whether NLRP3 could be involved in IL-1β maturation in response to the pore-forming toxin PopB.
As expected, NLRP3-blocked THP-1 human macrophages (using Bay11-7082) release less LDH and IL-1β when challenged with PopB, compared to the NLRP3-inflammasome Fig. 3 . Caspase-1 and IL-1β maturation in PscI-elicited human macrophages. Human monocyte cell line THP-1 was differentiated into macrophages with PMA. Cells were seeded in six-well culture plates and treated with fresh medium or 2 μg per well of PscI, PscF, PopB or LPS. Twenty-four hours post-contact, caspase-1 activation (A) and IL-1β maturation (B) were analyzed by immunoblots of culture supernatants and total cell lysates. Anti-actin immunoblot was used as a loading control. Fig. 4 . hNAIP-NLRC4 sensing of PscI-elicited human macrophages and PBMCs. Human monocyte cell line THP-1 (A-D) was differentiated into macrophages with PMA, and PBMCs (E) were isolated from peripheral venous blood. (A, B) Cells were seeded in 96-well culture plates and treated with fresh medium or 500 ng per well of ligands PscI, PscF, PopB, PrgI and MSU or 10 7 freeze-dried HKLM per well. Prior to treatment, cells were either left untreated or treated with the NLRP3 inhibitor Bay11-7082. The cytotoxicity (A) and the secretion of IL-1β (B) were determined 24 h post-contact by LDH release and ELISA. THP-1 cells (C, D) or PBMCs (E) were seeded in 24-well culture plates and were then transfected with NAIP1, NLRC4 or control siRNA. PscI at 500 ng or control medium were added per well. Relative gene expression was determined, 2 h post-contact, by quantitative RT-PCR (C); cytotoxicity and IL-1β secretion were determined by LDH release and ELISA (D, E). *P < 0.05; **P < 0.01; ***P < 0.001 compared to control. inducer, MSU. Conversely, the release of LDH and IL-1β triggered by PscI or PscF was not modified by blocking NLRP3 (Fig. 4A and B) . In the same manner, the Salmonella homolog of PscF, PrgI, is not modified by NLRP3 blockade. Thus, our data reveal that PopB is not recognized by TLR4 or 2 but by NLRP3 similarly to pore-forming toxins from other bacteria (12, 14, 15) .
Given that TLR4 plays a critical role in IL-1β induction, in order to reveal a possible hNAIP-NLRC4 sensing of PscI, we first blocked TLR4 with CLI-095 before silencing of hNAIP or NLRC4 expression. Thus, a 60% silencing of NLRC4 and hNAIP in human macrophages is associated with a significant 40% decrease of PscI-induced IL-1β and a decrease of PscI-induced LDH of 10% in NLRC4-silenced cells and a 20% decrease in hNAIP-silenced cells (Fig. 4C and D) . In the same conditions, PscI-induced IL-1β and LDH are both decreased in PBMCs (Fig. 4E) . Therefore, PscI is sensed in human at least in part by the hNAIP-NLRC4 pathway.
Our data are the first to show the implication of TLR signaling concomitantly to NLR signaling in the sensing of P. aeruginosa T3SS in human macrophages. Although differently situated within the T3SS, PscF and PscI are both polymer subunits and small helical proteins with similar coiled-coil regions and are considered as paralogs (16) . We previously showed in mice that the polymerization of PscI into fibrils is responsible for IL-1β increase (9) , suggesting that the tertiary and quaternary structure of the protein may be crucial to induce IL-1 synthesis. Therefore, the similarities in the sensing of PscI and PscF may be due to similar tertiary and quaternary structure.
Interestingly, while we observed hNAIP-NLRC4 inflammasome sensing of the P. aeruginosa inner-rod protein PscI, this differs from the absence of such sensing reported in response to S. enterica Typhimurium inner-rod protein PrgJ (8). PrgJ has been described to be a partially folded protein containing only a short helix domain (17) . Thus, while the tertiary and quaternary structure of P. aeruginosa PscI and PscF may explain similar sensing by the NAIP-NLRC4-inflammasome, a different structure of PrgJ may explain that it is not sensed by the NAIP-NLRC4-inflammasome. Taken together, these results suggest that it is probably not the location of innerrod proteins deep within the T3SS that confers innate immune recognition by the NAIP-NLRC4-inflammasome, but their structure. Likewise, the different structure of Salmonella PrgJ compared to Pseudomonas PscI may represent a mechanism for escaping NAIP-NLRC4-inflammasome recognition of human macrophages. Ours is the first description of the implication of the hNAIP-NLRC4-inflammasome in the sensing of the inner-rod protein PscI.
In conclusion, our data unveil that P. aeruginosa T3SS component proteins elicit the activation of several innate immune receptors (both TLRs and NLRs), leading to a strong pro-inflammatory response in human macrophages. Our results are consistent with recent data that provide genetic evidence for the important physiological function of NAIPs in antibacterial and inflammatory damage-induced lethality in mice (18) . Additionally, our results highlight that conversely to what is observed in mice in which specific NAIP proteins detect specific bacterial proteins in vivo (19) , bacterial protein recognition redundancy occurs in humans.
Taken together with our previous results showing that P. aeruginosa pathogenicity involves NLRC4-dependent recognition of the T3SS (3), our results suggest that PscI and PscF may be NLRC4-dependent virulence factors. Since simultaneously targeting multiple P. aeruginosa virulence factors using multivalent antibodies has been recently demonstrated as feasible and more effective (20) , blocking innate immune activation by blocking both PscI and PscF may represent an attractive therapeutic target to counter the deleterious effects of the P. aeruginosa T3SS.
